Clinical Trial Update: SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS) [Phase 2]

View source ↗

Summary

Sumitomo Pharma's SMP-986 completed a Phase 2 proof-of-concept trial in Overactive Bladder Syndrome. Results were posted in December 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• SMP-986

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Overactive Bladder Syndrome (OABS) | Phase 2 | Status: COMPLETED | Results posted: 2014-12-10